Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
KALA BIO, Inc. - Common Stock
(NQ:
KALA
)
4.140
-0.030 (-0.72%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 6, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about KALA BIO, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
July 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...
Via
Benzinga
Topics
Product Recall
Exposures
COVID-19
Legal
Product Safety
Stocks That Hit 52-Week Lows On Wednesday
July 07, 2021
Before 10 a.m. ET on Wednesday, 49 companies set new 52-week lows. Noteworthy Highlights: The largest company in terms of market cap to set a new 52-week low was China...
Via
Benzinga
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
June 18, 2021
From
Kala Pharmaceuticals, Inc.
Via
Business Wire
Kala Pharmaceuticals Announces EYSUVIS® Now Covered by OptumRx
June 03, 2021
From
Kala Pharmaceuticals, Inc.
Via
Business Wire
The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend
July 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6) Ambrx Biopharma Inc. (NYSE:...
Via
Benzinga
Kala Pharmaceuticals to Present at Jefferies 2021 Virtual Healthcare Conference
May 27, 2021
From
Kala Pharmaceuticals, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
July 06, 2021
Tuesday morning, 51 companies reached new 52-week lows. Noteworthy Highlights: China Life Insurance Co (NYSE:LFC) was the largest company by market cap to set a new...
Via
Benzinga
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
May 20, 2021
From
Kala Pharmaceuticals, Inc.
Via
Business Wire
Kala Pharmaceuticals to Present at BofA Securities 2021 Healthcare Conference
May 06, 2021
From
Kala Pharmaceuticals, Inc.
Via
Business Wire
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
May 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
May 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...
Via
Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
Kala Pharmaceuticals: Q1 Earnings Insights
May 05, 2021
Shares of Kala Pharmaceuticals (NASDAQ:KALA) fell 0.5% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 9.26%...
Via
Benzinga
Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 05, 2021
From
Kala Pharmaceuticals, Inc.
Via
Business Wire
Kala Pharmaceuticals Earnings Preview
May 04, 2021
Kala Pharmaceuticals (NASDAQ:KALA) announces its next round of earnings this Wednesday, May 05. Here is Benzinga's everything-that-matters guide for this Wednesday's Q1 earnings...
Via
Benzinga
Kala Pharmaceuticals to Report First Quarter 2021 Financial Results and Host Conference Call
April 28, 2021
From
Kala Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.